Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesMRIMRI-based model shows changes over time in multiple myeloma patientsWhole-body MRI could serve as a scalable biomarker for risk stratification in multiple myeloma patients.UltrasoundThyroid nodule classification systems provide diagnostic equityInterventionalY-90 TARE rises to top in treatments for liver transplant patientsUltrasoundUltrasound MinnieCast, Episode 16: How to create a sonography associationISeConsult systems may benefit radiology-provider communication